Investors eyeing a purchase of Oramed Pharmaceuticals Inc (ORMP) shares, but tentative about paying the going market price of $15.08/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $10 strike, which has a bid at the time of this writing of 70 cents..